ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Amedisys, Inc." (AMED) Report Updated: Jul 25, 2016 | Print This Page

Get more stock ratings by Louis Navellier

"Amedisys, Inc." (AMED)

Rating: Buy Volatility: Conservative
Total Grade: B Industry: Health Care Providers & Services
Competitors: WOOF,DRAD,CRVL,USMD

Stock Analysis

Rating: Monthly View

A
B
C
D
F
July August September October November December January February March April May June

Rating: Weekly View

This Week: B down no change
Last Week: B same no change
Two Weeks Ago: B up no change
service keys

"Amedisys, Inc."© quotemedia

Company Profile

Amedisys, Inc., together with its subsidiaries, provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The Home Health segment offers a range of services in the homes of individuals who may be recovering from illness, injury, or surgery. This segment provides skilled nurses, nurse practitioners, home health aides, physical and occupational therapists, speech therapists, and medical social workers; and chronic care clinical programs for patients with chronic diseases, such as cardiovascular, respiratory, diabetes, behavioral health, rehabilitative, and medical surgical conditions. The Hospice segment offers care that is designed to provide comfort and support for those who are facing a terminal illness, including heart disease, pulmonary disease, Alzheimer’s, HIV/AIDS, and cancer. As of December 31, 2014, the company owned and operated 316 Medicare-certified home health care centers and 80 Medicare-certified hospice care centers in 34 states within the United States, the District of Columbia, and Puerto Rico. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.